GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Deferred Tax

PharmaCielo (TSXV:PCLO) Deferred Tax : C$0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

PharmaCielo's change in deferred tax for the three months ended in Sep. 2024 was C$0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00 Mil.


PharmaCielo Deferred Tax Historical Data

The historical data trend for PharmaCielo's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Deferred Tax Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial - - - - -

PharmaCielo Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaCielo Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaCielo Deferred Tax Related Terms

Thank you for viewing the detailed overview of PharmaCielo's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaCielo Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of its revenue in the form of the Sale of Cannabis derivative products in Colombia.
Executives
Ian D Atacan Director, Senior Officer
Marc Lustig Director
William Boris Petron Director
Henning Von Koss Director, Senior Officer
Anthony Wile 10% Security Holder

PharmaCielo Headlines